Safety evaluation of oral calcitonin-gene–related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis Seoyeon LeeChristine E. StaatzIn-hwan Baek Review 22 June 2022 Pages: 1365 - 1376
Strategies to manage auxiliary pain medications in chronic pain trials: a topical review Eivind HasvikJon Michael GranLars Grøvle Review Open access 16 July 2022 Pages: 1377 - 1384
Evolution of adverse drug reactions reporting systems: paper based to software based M. T. MadhushikaT. P. WeerarathnaS. S. Jayasinghe Review 05 July 2022 Pages: 1385 - 1390
Ticagrelor versus clopidogrel in reducing inflammatory cell infiltration of thrombus aspirated in patients with ST-elevation myocardial infarction Jing ShenGuangzhong LiuYe Tian Clinical Trial 08 June 2022 Pages: 1391 - 1398
Scientific and ethical issues in add-on designs for antidiabetic drugs Lidia StaszewskySilvio Garattini Clinical trial 22 June 2022 Pages: 1399 - 1401
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis Shaodi MaWanying SuYehuan Sun Clinical Trial 22 June 2022 Pages: 1403 - 1420
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis Lingxiao ZhangLiangying GanQingshan Zheng Pharmacokinetics and Disposition Open access 17 June 2022 Pages: 1421 - 1434
Physiologically based pharmacokinetic combined BTK occupancy modeling for optimal dosing regimen prediction of acalabrutinib in patients alone, with different CYP3A4 variants, co-administered with CYP3A4 modulators and with hepatic impairment Lifang XuShuang YuYang Liu Pharmacokinetics and Disposition 09 June 2022 Pages: 1435 - 1446
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy Weikun HuangYou ZhengXuemei Wu Pharmacokinetics and Disposition 28 June 2022 Pages: 1447 - 1457
Prevalence and initiation of statin therapy in the oldest old—a longitudinal population-based study Helena SundvallSigurd VitolsJohan Fastbom Pharmacoepidemiology and Prescription Open access 05 July 2022 Pages: 1459 - 1467
Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey Tessa Corrine Catherina JaspersA. KeyanyN. Khorsand Pharmacoepidemiology and Prescription Open access 17 June 2022 Pages: 1469 - 1479
Opioid use among Danish patients with severe knee osteoarthritis: a drug utilization study Matilde LundbergMelker Staffan JohanssonJonas Bloch Thorlund Pharmacoepidemiology and Prescription 13 June 2022 Pages: 1481 - 1486
Antihypertensive prescribing pattern, prescriber adherence to ISH 2020 guidelines, and implication of outpatient drug price on blood pressure control at selected hospitals in Southern Ethiopia Mende Mensa SoratoMajid DavariTamiru Shibru Pharmacoepidemiology and Prescription 16 June 2022 Pages: 1487 - 1502
DRESS characteristics according to the causative medication A. ChaabaneH. Ben RomdhaneK. Aouam Pharmacoepidemiology and Prescription 20 June 2022 Pages: 1503 - 1510
Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use Irene MattioliAlessandra Bettiolthe MEREAFaPS Study group Pharmacoepidemiology and Prescription Open access 22 June 2022 Pages: 1511 - 1519
Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase Qingxia ZhangQian DingQun-Ying Yue Pharmacoepidemiology and Prescription Open access 01 July 2022 Pages: 1521 - 1526
Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study Adriana Nancy Medeiros dos SantosGuilherme Amorim Avilla Gimenez JuniorClaudia Kimie Suemoto Pharmacoepidemiology and Prescription 28 June 2022 Pages: 1527 - 1534